Het Universitair Ziekenhuis Antwerpen is het universitair ziekenhuis van de Universiteit Antwerpen.

During the past decade, Universitair Ziekenhuis Antwerpen conducted 343 clinical trials. In the 10-year time frame, 343 clinical trials started and 117 clinical trials were completed, i.e. on average, 34.1% percent of trials that started reached the finish line to date. In the past 5 years, 162 clinical trials started and 78 clinical trials were completed. i.e. 48.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitair Ziekenhuis Antwerpen" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 86 trials, followed by "Hoffmann-La Roche" with 42 trials sponsored, "Janssen Research & Development, LLC" with 19 trials sponsored, "Amgen" with 18 trials sponsored and "Boehringer Ingelheim" with 18 trials sponsored. Other sponsors include 356 different institutions and companies that sponsored additional 188 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitair Ziekenhuis Antwerpen" #1 collaborator was "Universiteit Antwerpen" with 10 trials as a collaborator, "University Hospital, Antwerp" with 9 trials as a collaborator, "Merck Sharp & Dohme LLC" with 8 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 7 trials as a collaborator and "AstraZeneca" with 6 trials as a collaborator. Other collaborators include 297 different institutions and companies that were collaborators in the rest 232 trials.

According to Clinical.Site data, the most researched conditions in "Universitair Ziekenhuis Antwerpen" are "Breast Cancer" (23 trials), "Multiple Myeloma" (16 trials), "Leukemia" (11 trials), "Crohn Disease" (10 trials) and "Endometrial Cancer" (9 trials). Many other conditions were trialed in "Universitair Ziekenhuis Antwerpen" in a lesser frequency.

Most popular intervention types in "Universitair Ziekenhuis Antwerpen" are "Drug" (410 trials), "Biological" (59 trials), "Other" (44 trials), "Device" (42 trials) and "Procedure" (42 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (97 trials), "Paclitaxel" (21 trials), "cisplatin" (21 trials), "radiation therapy" (19 trials) and "Docetaxel" (15 trials). Other intervention names were less common.

The vast majority of trials in "Universitair Ziekenhuis Antwerpen" are 483 trials for "All" genders, 45 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are 199 active trials in "Universitair Ziekenhuis Antwerpen". 1 are not yet recruiting, 117 are recruiting, 79 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 258 completed trials in Universitair Ziekenhuis Antwerpen, 3 suspended trials, and 43 terminated clinical trials to date.

Out of the total trials that were conducted in Universitair Ziekenhuis Antwerpen, 69 "Phase 1" clinical trials were conducted, 177 "Phase 2" clinical trials and 205 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 18 trials, and there were also 43 trials that are defined as “Not Applicable".

Universitair Ziekenhuis Antwerpen has several departments that took part in Clinical trials: "Universitair Ziekenhuis Antwerpen Oncologie" - 4 trials, "UZ AntwerpenDienst nefrologie" - 3 trials, "Universitair Ziekenhuis Antwerpen, Gastro-Enterologie," - 3 trials, "Dienst Cardiale Revalidatie, Cardiologie, Universitair Ziekenhuis Antwerpen" - 2 trials